Evaluation of D-dimer Level in COVID-19 Patients
Open Access
- 15 January 2026
- journal article
- Published by Iraqi Association for Medical Research and Studies in Iraqi National Journal of Medicine
- Vol. 8 (1) , 56-62
Abstract
Background: The COVID-19 pandemic is associated with prothrombotic complications, leading to increased morbidity and mortality. D-dimer, a fibrin degradation product, serves as a biomarker for coagulation abnormalities. This study evaluates the role of D-dimer in predicting disease severity and hospitalization in COVID-19 patients. Aim: To assess correlations between D-dimer levels and age, gender, comorbidities, disease severity, and hospitalization needs in COVID-19 patients. Methods: A retrospective analysis of 78 COVID-19-positive patients admitted to an outpatient clinic was conducted. Data on demographics, comorbidities, vaccination status, disease severity, and admission D-dimer levels were analyzed using statistical tests (t-tests, chi-square, Mann-Whitney U). Results: The mean age of participants was 49 years, with 56.4% males and 43.6% females. Approximately 52% of patients had a comorbid disease, primarily hypertension and diabetes. Older patients and those with coexisting diseases had significantly higher D-dimer levels (p-values 0.017 and 0.045, respectively), with non-significant differences between males and females (p-value 0.648). Older patients had a significantly higher need for hospitalization during acute COVID-19 infection (p-value 0.002). Additionally, patients with elevated admission D-dimer levels showed a greater prevalence of severe disease (p-value 0.01) and a higher need for hospitalization (p-value 0.028). Conclusions: Elevated admission D-dimer levels are strongly linked to severe COVID-19 outcomes and hospitalization, highlighting their utility as an early prognostic marker. Clinical management of COVID-19 patients may be guided by D-dimer assessment, which may help predict disease severity.Keywords
This publication has 32 references indexed in Scilit:
- How Does COVID-19 Affect the Heart?Current Cardiology Reports, 2023
- Modifiable contributing factors to COVID-19: A comprehensive reviewFood and Chemical Toxicology, 2022
- COVID-19 and thrombosis: The role of hemodynamicsThrombosis Research, 2022
- Utility of a shortened Hasegawa Dementia Scale Revised questionnaire to rapidly screen and diagnose Alzheimer’s diseaseAging Medicine, 2021
- NLR and CRP to albumin ratio as a predictor of in-hospital mortality in the geriatric ED patientsThe American Journal of Emergency Medicine, 2021
- A systematic review and meta-analysis of geographic differences in comorbidities and associated severity and mortality among individuals with COVID-19Scientific Reports, 2021
- Impact of age, sex, comorbidities and clinical symptoms on the severity of COVID-19 cases: A meta-analysis with 55 studies and 10014 casesHeliyon, 2020
- Effect of metformin and insulin combination on monocyte chemoattractant protein-1 and cathepsin-D in type 2 diabetes mellitusDiabetes & Metabolic Syndrome: Clinical Research & Reviews, 2020
- Older Adults Hospitalized with Covid-19: Clinical Characteristics and Early Outcomes from a Single Center in Istanbul, TurkeyThe Journal of nutrition, health and aging, 2020
- MED-TMA: A clinical decision support tool for differential diagnosis of TMA with enhanced accuracy using an ensemble methodThrombosis Research, 2020